News

The collaboration reflects Ebn Sina Medical’s commitment to delivering high-quality medicinal products to the local market, ...
Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment landscape for head and neck and lung cancer, and implications for specific drug ...
In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company ...
Summit Therapeutics (NASDAQ:SMMT) stock extends gains as lead cancer drug ivonescimab developed with Akeso (AKESF) ...
BeiGene stock has formed an early-stage base with a buy point of 287.88 ahead of its first-quarter results on May 7.
Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund launched on 06/19/2006. What ...